These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897 [TBL] [Abstract][Full Text] [Related]
58. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue. Giménez A; Minguela A; de Haro LM; Parrilla P; Bermejo J; Pérez D; García AM; Ortiz MA; Molina J; Alvarez R World J Surg; 2000 Jan; 24(1):72-7. PubMed ID: 10594207 [TBL] [Abstract][Full Text] [Related]
59. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus. Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858 [TBL] [Abstract][Full Text] [Related]
60. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus. Hennig EE; Mikula M; Orlowska J; Jarosz D; Bielasik A; Regula J; Ostrowski J J Mol Med (Berl); 2008 Feb; 86(2):233-42. PubMed ID: 17952395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]